Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Diabetes Management During Breastfeeding in Women with Type 1 Diabetes

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Academic performance in adolescents born to mothers with gestational diabetes - a national Danish cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Gestational diabetes mellitus and stigma: A scoping review

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

Vis graf over relationer

In women with preexisting diabetes and nephropathy or microalbuminuria, it is important to deliver careful preconception counselling to assess the risk for the mother and the foetus, for optimizing glycaemic status and to adjust medical treatment. If serum creatinine is normal in early pregnancy, kidney function is often preserved during pregnancy, but complications such as severe preeclampsia and preterm delivery are still common. Perinatal mortality is now comparable with that in women with diabetes and normal kidney function. Besides strict glycaemic control before and during pregnancy, early and intensive antihypertensive treatment is important to optimize pregnancy outcomes. Methyldopa, labetalol, nifedipine and diltiazem are considered safe, whereas angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers should be stopped before or at confirmation of pregnancy. Supplementation with folic acid in early pregnancy and low-dose aspirin from 10 to 12 weeks reduces the risk of adverse pregnancy outcomes. During breastfeeding, several ACE inhibitors are considered safe.

OriginalsprogEngelsk
TidsskriftCurrent Diabetes Reports
Vol/bind16
Udgave nummer2
Sider (fra-til)12
ISSN1534-4827
DOI
StatusUdgivet - feb. 2016

ID: 49766296